Where does Nectero Medical, Inc rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nectero Medical, Inc ranks #49,006 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nectero Medical, Inc hold?

Nectero Medical, Inc holds 5 US utility patents granted between 2018 and 2025, spanning 7 technology areas.

What is Nectero Medical, Inc's Innovation Score?

Nectero Medical, Inc has an Innovation Score of 41.0 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Nectero Medical, Inc's patent grant rate increasing or decreasing?

Nectero Medical, Inc's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Nectero Medical, Inc's patents?

Nectero Medical, Inc's patents average 20.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nectero Medical, Inc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nectero Medical, Inc

Q: What technology areas does Nectero Medical, Inc focus on?

Nectero Medical, Inc's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 5 patents. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nectero ranks #49,006 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.

#49,006
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.0/100): 20.2
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R49006 · US Corporation #49,006 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,006/49,997
PHOTO-FINISH Navitas Solutions
CPC-NARROW A61M · 7 areas
INNOV-PAR 41.0/100
CLAIMS-DENSE 20.2 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Navitas Solutions, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Nectero Medical · this assignee

41
3D Lighting… · lowest

7

What this shows Nectero's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Nectero's grants concentrate

Nectero Medical, Inc is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2022. By volume, Nectero sits between Navitas Solutions, Inc. and Neomend, Inc..

Nectero's three-year grant acceleration

Nectero Medical, Inc shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Navitas Solutions

5
Nexolve Holding

5
Near-miss Managem…

5
Necksgen

5
Neo Mechanics

5
Neodiagnostix

5
Neogenis Labs

5
Neomend

5
Nectero Medical ◀

5

What this shows Nectero holds 5 patents at rank #49,131, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nectero

By rank, the assignees closest to #49,131 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Nectero's primary technology class.

Nectero's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Nectero Medical, Inc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	40.0%
2022	1	20.0%
2024	1	20.0%
2025partial year	1	20.0%

Which technologies does Nectero Medical, Inc patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

A61B - DIAGNOSIS; SURGERY; Identification 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#49,006

of 49,997 tracked assignees

Innovation Score

41.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Nectero Medical, Inc's patent record in context - here's where to go next.

Nectero Medical, Inc's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 100% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #49,006 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nectero Medical, Inc against Navitas Solutions, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.